News and Media
Latest news
Accord Healthcare nominated for 'Pf 2024' award
Read MoreWorld Cancer Day 2024: Accord committed to helping close the gap in cancer care
Read MoreAccord wins four ‘Pharmaceutical Technology Excellence’ awards
Read MoreAccord in 2023: Watch our End of Year video
Read MoreAccord Healthcare wins ‘CSR World Leader 2023’ award
Read MoreAccord Healthcare launches Accord Animal Health
Read MoreAccord Supporting World Menopause Day 2023
Read MoreSupporting IHP
Read MoreEuropean-wide legal guidance on medicines procurement
Read MorePressures on the pharmaceutical industry with The Generics Bulletin
Read MoreAccord Healthcare – The Guardian Future of Healthcare - Q1 2023
Read MoreAccord Womens Network
Read MoreAccord Healthcare marks World Cancer Day 2023
Read MoreAccord's approach to reducing environmental impact
Read MoreAccord and IHP at Christmas
Read MoreWe are delighted to be named winners at the Global Generics & Biosimilars 2022 Awards in Frankfurt.
Read MoreThank you to everyone who attended CPHI2022
Read MoreGrad Week 2022
Read MoreThe Times - Future of Pharma Supplement
Read MoreGGb Finalist
Read MoreInnovations in Oncology
Read MoreDepartment of International Trade and Health and Invest Newcastle Visit Accord’s Fawdon Site
Read MoreAccord Healthcare featured in The Guardian
Read MoreScience Jobs
Read MoreIHP Visit Fawdon
Read MoreSupporting IHP to Make it Better for those in Ukraine and beyond
Read MoreAccord Germany Turns 10
Read MoreAsk Accord - Peter Kelly
Read MoreBREAKING NEWS – New Partnership for Oncology Franchise
Read MoreEmployee Spotlight
Read MoreAccord Linkedin
Once more, Accord Healthcare earns a spot among the finalists at the prestigious Pf Awards, this time in the Patient Impact category. This nomination recognises our unwavering dedication to the Medicines Repurposing Programme, in collaboration with NHS England. It's a moment that underscores our commitment to pioneering new pathways in healthcare and increasing access to vital medicines for patients.
We are grateful to be shortlisted amongst an impressive array of entries. This nomination reflects our collective ambition to elevate healthcare standards, with a keen focus on enhancing quality, safety, and broadening treatment options in partnership with entities like the MHRA and NHS England.
Hats off to our Regulatory teams for their remarkable dedication and pursuit of excellence. Their pivotal contributions have been instrumental in achieving this notable recognition.
Wish us luck!